hrcak mascot   Srce   HID

Acta Pharmaceutica, Vol.67 No.3 Rujan 2017.

Kratko priopćenje
DOI: 10.1515/acph-2017-0022

Pharmacological activities of some triazinopyrazolothieno pyrimidine derivatives

SALEH A. BAHASHWAN ; Taibah University, Faculty of Pharmacy, Department of Pharmacology and Toxicology, Madinah Munawara, Saudi Arabia

Puni tekst: engleski, pdf (783 KB) str. 407-414 preuzimanja: 37* citiraj
APA
BAHASHWAN, S.A. (2017). Pharmacological activities of some triazinopyrazolothieno pyrimidine derivatives. Acta Pharmaceutica, 67(3). doi:10.1515/acph-2017-0022

Sažetak
Triazinopyrazolothieno pyrimidine derivatives 1–5 were evaluated for their anti-inflammatory, analgesic and anticancer activities and acute toxicity. Anti-inflammatory activity of the compounds was studied using the carrageenan test. All tested compounds showed analgesic activity, 3-methoxycarbonyl-4,6-dimethyl-8-[(N-methylindolyl)methyl]pyrimido [5',4':4,5]thieno [3',2'-3,4]pyrazolo [5,1-c]triazine (4) showed activity comparable to that of diclofenac. Compounds 1–5 were also screened for anticancer activity on a human lung cancer cell line (A549) and a human prostate cancer cell line (DU145) using the MTT micro-cultured tetrazolium assay method. Compound 4 showed also significant anticancer activity against both cancer cell lines, comparable to that of doxorubicin. The most active compounds were tested for their acute toxicity and median lethal doses were evaluated.

Ključne riječi
pyrimidine derivatives; triazinopyrazolothieno; anti-inflammatory; analgesic; anticancer; acute toxicity

Hrčak ID: 181129

URI
http://hrcak.srce.hr/181129

Posjeta: 65 *